Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06579703 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT06579703 · ClinicalTrials.gov record · last posted 2024-08-30

Ketorolac for Acute Vaso-Occlusive Crisis in Pediatric Sickle Cell Disease

Name: Ketorolac for Acute Vaso-Occlusive Crisis in Pediatric Sickle Cell Disease — clinical trial record (NCT06579703)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 4

SponsorChildren's Blood and Cancer Center at Dell Children's Medical Center

Started2024-09-30

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

Pediatric patients who present with acute vaso-occlusive pain crisis may have equivalent pain reduction scores at lower dosing of intravenous Ketorolac compared to standard dosing of 0.5 mg/kg/dose IV (\<16yo max 15mg, \>16yo max 30mg) x 1 dose.

Trial Details

NCT Number	NCT06579703
Lead Sponsor	Children's Blood and Cancer Center at Dell Children's Medical Center
Conditions	Sickle Cell Disease, Sickle Cell Crisis, Veno-occlusive Disease
Enrollment	102 participants
Start Date	2024-09-30
Primary Completion	2027-07-01 (estimated)
Study Completion	2028-02-15 (estimated)
Updated on ClinicalTrials.gov	2024-08-30